Vimarsana
Biggest News Aggregation in the World

Page 4 - Ocular Presentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocular Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocular Presentation Today - Breaking & Trending Today

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million From the Exercise of Previously Issued Class A Warrants - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million From the Exercise of Previously Issued Class A Warrants

Salt Lake City, Utah--(Newsfile Corp. - November 18, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced today it has entered into warrant inducement offer letters

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Doses First Patient in ABACUS Phase 1b Study Evaluating KIO-301 for Retinitis Pigmentosa - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Doses First Patient in ABACUS Phase 1b Study Evaluating KIO-301 for Retinitis Pigmentosa

Salt Lake City, Utah--(Newsfile Corp. - November 17, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced today the dosing of the first patient in a first-in-human open-label

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Provides 3rd Quarter 2022 Business and Financial Update; Dosing of KIO-301 in Phase 1 Trial for Retinitis Pigmentosa to Begin Before Year's End - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Provides 3rd Quarter 2022 Business and Financial Update; Dosing of KIO-301 in Phase 1 Trial for Retinitis Pigmentosa to Begin Before Year's End

Salt Lake City, Utah--(Newsfile Corp. - November 9, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Salt Lake City, Utah--(Newsfile Corp. - October 13, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today that it has received a Bid Price Compliance Letter from

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance

Salt Lake City, Utah--(Newsfile Corp. - September 13, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") has appointed Melissa Tosca as Executive Vice President of Finance.